Approvals/TGA/FLIXOTIDE JUNIOR (CFC-FREE) INHALER fluticasone propionate 50 microgram/actuation

Approved

STANDARD

FLIXOTIDE JUNIOR (CFC-FREE) INHALER fluticasone propionate 50 microgram/actuation

GlaxoSmithKline Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ef087ed447913f78
Product Name: FLIXOTIDE JUNIOR (CFC-FREE) INHALER fluticasone propionate 50 microgram/actuation
Artg Id: 76865
Artg Name: FLIXOTIDE JUNIOR (CFC-FREE) INHALER fluticasone propionate 50 microgram/actuation inhalation-pressurised aerosol can-metered dose
Sponsor: GlaxoSmithKline Australia Pty Ltd
Company Detail Path: /organization/glaxosmithkline-australia-pty-ltd
Artg Date: 2001-01-24
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/3343dc13674bafba1e64e271f011b3d0.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/319d1725b460d2c26bbcf61b573958d8.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

ef087ed447913f78

Type

Standard